
Diagnoly helps clinicians improve prenatal screening by providing real‑time AI analysis of fetal ultrasound to detect abnormalities and ensure complete exams. It builds Fetoly, a DeepTech B2B SaaS and medical device that uses AI and deep learning models integrated with ultrasound systems to provide on‑device, real‑time feedback during scans. Fetoly analyzes anatomical landmarks, detects over 100 fetal abnormalities, validates exam completeness against ISUOG guidelines, and automates repetitive measurements to increase consistency. The solution runs locally on mobile devices and remains compatible with major ultrasound platforms without requiring cloud services, preserving clinical data control. Diagnoly targets obstetricians and healthcare providers and holds FDA clearance for Fetoly‑Heart and CE marking for fetal heart and brain analysis.

Diagnoly helps clinicians improve prenatal screening by providing real‑time AI analysis of fetal ultrasound to detect abnormalities and ensure complete exams. It builds Fetoly, a DeepTech B2B SaaS and medical device that uses AI and deep learning models integrated with ultrasound systems to provide on‑device, real‑time feedback during scans. Fetoly analyzes anatomical landmarks, detects over 100 fetal abnormalities, validates exam completeness against ISUOG guidelines, and automates repetitive measurements to increase consistency. The solution runs locally on mobile devices and remains compatible with major ultrasound platforms without requiring cloud services, preserving clinical data control. Diagnoly targets obstetricians and healthcare providers and holds FDA clearance for Fetoly‑Heart and CE marking for fetal heart and brain analysis.
Product: Fetoly — on-device, real-time AI for fetal ultrasound (landmarking, QA, anomaly detection)
Regulatory: FDA clearance for Fetoly-Heart and CE marking for fetal heart and brain analysis
Founded: 2020 — Lyon, France
Latest funding: Seed round announced Apr 8, 2025 (€5.5M reported)
Prenatal fetal ultrasound quality assurance and anomaly detection
2020
Medical Equipment Manufacturing
€5.5M
Reported seed round announced Apr 8, 2025; participants include Mutuelles Impact, Newfund and existing investor BAdGE
Profiles list multiple prior funding events and non-equity assistance but details not specified in evidence
“Mutuelles Impact and Newfund participate as lead investors in the Seed round; additional investors reported across rounds include XAnge, Les Business Angels des Grandes Écoles, WorldUpstart, Angelor, MassChallenge Switzerland”
| Company |
|---|
Start-up activity
DIAGNOLY is a DeepTech start-up headquartered in Lyon, France. Our aim is to improve fetal screening and simplify obstetric ultrasound technique for the doctor. To do so, we develop an intelligent medical hardware device that will be connected to ultrasound machines. Analyzing the fetal examination in real time, our product will help doctors to detect the most complex fetal pathologies prenatally.
Increasing significantly prenatal detection rate of fetal pathologies, our product will reduce the risk of lifelong disabilities, handicap or lethal outcomes for concerned babies.
Do you have an extensive experience in mobile development? Are you looking to be at the beginning of a new adventure and to make a larger impact in a smaller company?
Then this role is for you!
We are looking for a developer, ready for the challenge of building an innovative architecture for medical software device deployed to tablets; Someone who is ready to redefine our software development and engineering practice, provide vision and leadership.
We are seeking candidates who have a strong background working within industrial software development.
Your missions
Required knowledge and skills
Preferred
If you are interested, do not hesitate to write us on careers@diagnoly.com